» Articles » PMID: 29305551

Development and Evaluation of a Broad Bead-Based Multiplex Immunoassay To Measure IgG Seroreactivity Against Human Polyomaviruses

Overview
Specialty Microbiology
Date 2018 Jan 7
PMID 29305551
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The family of polyomaviruses, which cause severe disease in immunocompromised hosts, has expanded substantially in recent years. To accommodate measurement of IgG seroresponses against all currently known human polyomaviruses (HPyVs), including the Lyon IARC polyomavirus (LIPyV), we extended our custom multiplex bead-based HPyV immunoassay and evaluated the performance of this pan-HPyV immunoassay. The VP1 proteins of 15 HPyVs belonging to 13 species were expressed as recombinant glutathione -transferase (GST) fusion proteins and coupled to fluorescent Luminex beads. Sera from healthy blood donors and immunocompromised kidney transplant recipients were used to analyze seroreactivity against the different HPyVs. For BK polyomavirus (BKPyV), the GST-VP1 fusion protein-directed seroresponses were compared to those obtained against BKPyV VP1 virus-like particles (VLP). Seroreactivity against most HPyVs was common and generally high in both test populations. Low seroreactivity against HPyV9, HPyV12, New Jersey PyV, and LIPyV was observed. The assay was reproducible (Pearson's > 0.84, < 0.001) and specific. Weak but consistent cross-reactivity between the related viruses HPyV6 and HPyV7 was observed. The seroresponses measured by the GST-VP1-based immunoassay and a VP1 VLP-based enzyme-linked immunosorbent assay were highly correlated (Spearman's ρ = 0.823, < 0.001). The bead-based pan-HPyV multiplex immunoassay is a reliable tool to determine HPyV-specific seroresponses with high reproducibility and specificity and is suitable for use in seroepidemiological studies.

Citing Articles

Prevalence and in vitro study of human polyomavirus 9.

Katona M, Jeles K, Takacs P, Csoma E Sci Rep. 2024; 14(1):29313.

PMID: 39592793 PMC: 11599758. DOI: 10.1038/s41598-024-80806-3.


BK polyomavirus: latency, reactivation, diseases and tumorigenesis.

Zhou X, Zhu C, Li H Front Cell Infect Microbiol. 2023; 13:1263983.

PMID: 37771695 PMC: 10525381. DOI: 10.3389/fcimb.2023.1263983.


Serology Identifies LIPyV as a Feline Rather than a Human Polyomavirus.

Kamminga S, van der Meijden E, Pesavento P, Buck C, Feltkamp M Viruses. 2023; 15(7).

PMID: 37515232 PMC: 10384086. DOI: 10.3390/v15071546.


Novel polyomaviruses identified in fecal samples from four carnivore species.

Kraberger S, Serieys L, Riley S, Schmidlin K, Newkirk E, Squires J Arch Virol. 2023; 168(1):18.

PMID: 36593361 PMC: 10681122. DOI: 10.1007/s00705-022-05675-5.


Tetraplex Fluorescent Microbead-Based Immunoassay for the Serodiagnosis of Newcastle Disease Virus and Avian Influenza Viruses in Poultry Sera.

Zhao N, Grund C, Beer M, Wang G, Harder T Pathogens. 2022; 11(9).

PMID: 36145491 PMC: 9505202. DOI: 10.3390/pathogens11091059.


References
1.
Gossai A, Waterboer T, Nelson H, Michel A, Willhauck-Fleckenstein M, Farzan S . Seroepidemiology of Human Polyomaviruses in a US Population. Am J Epidemiol. 2015; 183(1):61-9. PMC: 5006224. DOI: 10.1093/aje/kwv155. View

2.
Gheit T, Dutta S, Oliver J, Robitaille A, Hampras S, Combes J . Isolation and characterization of a novel putative human polyomavirus. Virology. 2017; 506:45-54. PMC: 9265179. DOI: 10.1016/j.virol.2017.03.007. View

3.
Gardner S, Field A, Coleman D, HULME B . New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet. 1971; 1(7712):1253-7. DOI: 10.1016/s0140-6736(71)91776-4. View

4.
Viscidi R, Clayman B . Serological cross reactivity between polyomavirus capsids. Adv Exp Med Biol. 2006; 577:73-84. DOI: 10.1007/0-387-32957-9_5. View

5.
Siebrasse E, Reyes A, Lim E, Zhao G, Mkakosya R, Manary M . Identification of MW polyomavirus, a novel polyomavirus in human stool. J Virol. 2012; 86(19):10321-6. PMC: 3457274. DOI: 10.1128/JVI.01210-12. View